Ligand Pharmaceuticals reported 43.03 in PE Price to Earnings for its fiscal quarter ending in March of 2025.


Pe Change Date
Amgen 12.51 28.7 Jun/2025
Arrowhead Research 436.79 383.28 Jun/2020
Baxter International 21.56 95.08 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Eli Lilly 37 7.55 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Glaxosmithkline 18.39 3.81 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 43.03 4.09 Mar/2025
Merck 8.58 4.74 Jun/2025
Pacira 23.09 5.46 Jun/2025
Pfizer 9.12 8.86 Jun/2025
Veracyte 42.66 21.92 Jun/2025